Interactive competition between homologous recombination and non-homologous end joining
- PMID: 14573792
Interactive competition between homologous recombination and non-homologous end joining
Abstract
DNA-dependent protein kinase (DNA-PK), composed of Ku70, Ku80, and the catalytic subunit (DNA-PKcs), is involved in double-strand break (DSB) repair by non-homologous end joining (NHEJ). DNA-PKcs defects confer ionizing radiation sensitivity and increase homologous recombination (HR). Increased HR is consistent with passive shunting of DSBs from NHEJ to HR. We therefore predicted that inhibiting the DNA-PKcs kinase would increase HR. A novel DNA-PKcs inhibitor (1-(2-hydroxy-4-morpholin-4-yl-phenyl)-ethanone; designated IC86621) increased ionizing radiation sensitivity but surprisingly decreased spontaneous and DSB-induced HR. Wortmannin also inhibits DNA-PKcs and reduces DSB-induced HR. IC86621 did not affect HR product outcome, indicating that it affects HR initiation. Thus, HR is increased in the absence of DNA-PKcs, but decreased when DNA-PKcs is catalytically inactive, suggesting interactive competition between HR and NHEJ. The effects of IC86621 and wortmannin were proportional to the level of DNA-PKcs, consistent with inhibited DNA-PKcs acting in a dominant negative manner. We propose that inhibition of DNA-PKcs blocks its autophosphorylation, prevents dissociation of DNA-PKcs from DNA ends, and thereby blocks both HR and NHEJ. By blocking the two major DSB repair pathways, DNA-PKcs inhibitors should radiosensitize at all cell-cycle stages and are therefore excellent candidates for augmenting cancer radiotherapy.
Similar articles
-
Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.Mutat Res. 2008 Nov 10;646(1-2):8-16. doi: 10.1016/j.mrfmmm.2008.08.013. Epub 2008 Sep 4. Mutat Res. 2008. PMID: 18812179
-
DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells.J Mol Biol. 2001 Apr 13;307(5):1235-45. doi: 10.1006/jmbi.2001.4564. J Mol Biol. 2001. PMID: 11292338
-
The kinase activity of DNA-PK is required to protect mammalian telomeres.DNA Repair (Amst). 2004 Mar 4;3(3):225-33. doi: 10.1016/j.dnarep.2003.10.013. DNA Repair (Amst). 2004. PMID: 15177038
-
Regulation of DNA double-strand break repair pathway choice.Cell Res. 2008 Jan;18(1):134-47. doi: 10.1038/cr.2007.111. Cell Res. 2008. PMID: 18157161 Review.
-
Mechanisms of DNA double strand break repair and chromosome aberration formation.Cytogenet Genome Res. 2004;104(1-4):14-20. doi: 10.1159/000077461. Cytogenet Genome Res. 2004. PMID: 15162010 Review.
Cited by
-
Misrepair of DNA double-strand breaks after exposure to heavy-ion beams causes a peak in the LET-RBE relationship with respect to cell killing in DT40 cells.J Radiat Res. 2013 Nov 1;54(6):1029-35. doi: 10.1093/jrr/rrt064. Epub 2013 May 30. J Radiat Res. 2013. PMID: 23722078 Free PMC article.
-
Quantitation of DNA double-strand break resection intermediates in human cells.Nucleic Acids Res. 2014 Feb;42(3):e19. doi: 10.1093/nar/gkt1309. Epub 2013 Dec 19. Nucleic Acids Res. 2014. PMID: 24362840 Free PMC article.
-
DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer.Biomolecules. 2015 Nov 20;5(4):3204-59. doi: 10.3390/biom5043204. Biomolecules. 2015. PMID: 26610585 Free PMC article. Review.
-
Progression of chromosomal damage induced by etoposide in G2 phase in a DNA-PKcs-deficient context.Chromosome Res. 2015 Dec;23(4):719-32. doi: 10.1007/s10577-015-9478-4. Epub 2015 Jul 8. Chromosome Res. 2015. PMID: 26152239
-
Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.Br J Pharmacol. 2013 Aug;169(8):1745-65. doi: 10.1111/bph.12244. Br J Pharmacol. 2013. PMID: 23682925 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials